The role of chronic hyperviscosity in vascular disease

Therapeutic Advances in Cardiovascular Disease

Volumn 9, Issue 1, 2015, Pages 19-25

  Sloop, Gregory ^a   Holsworth, Ralph E ^b   Weidman, Joseph J ^c   Cyr, John A ^d  

^a Benefis Health System   (United States)

^b Long Term Care Center   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Jacqmar Inc   (United States)

Author keywords

atherosclerosis; blood viscosity; hypertension; metabolic syndrome; thrombosis

Indexed keywords

LIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; DALCETRAPIB; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TORCETRAPIB;

BLOOD VISCOSITY; CHRONIC DISEASE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; PHLEBOTOMY; PHYSIOLOGY; PLAQUE, ATHEROSCLEROTIC; VASCULAR DISEASES; ARTERIAL STIFFNESS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INSULIN RESISTANCE; IRON DEFICIENCY ANEMIA; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALT INTAKE; SHEAR RATE; SKELETAL MUSCLE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTOSIS; THROMBOSIS; VASCULAR DISEASE;

BLOOD VISCOSITY; CHRONIC DISEASE; HUMANS; HYPERTENSION; LIPOPROTEINS; METABOLIC SYNDROME X; PHLEBOTOMY; PLAQUE, ATHEROSCLEROTIC; VASCULAR DISEASES;

EID: 84921333994     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944714553226     Document Type: Review

References (40)

1. Antonova N. Velcheva J. (1999) Hemorheologic disturbances and characteristic parameters in patients with cerebrovascular disease. Clin Hemorheol Microcirc 21:405–408.
2. Brousseau M. Schaefer E. Wolfe M. Bloedon L. Digenio A. Clark R. et al. (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350: 1505–1515.
3. Campos J. Blijlevens E. McNamara J. Ordovas J. Posner B. Wilson P. et al. (1992) LDL particle size distribution. Results from the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 12: 1410-1419.
4. Cecchi E. Gigliolo C. Valente S. Lazzeri C. Gensini G. Abbate R. et al. (2011) Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis 214: 249–256.
5. Clivillé X. Bofill C. Joven J. Monasterio J. Viscor G. Vernis M. et al. (1998) Hemorheological, coagulative and fibrinolytic changes during autologous blood donation. Clin Hemorheol Microcirc 18: 265–272.
6. Del Zoppo G. (2008) Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 5(Suppl. 1): S12–S21.
7. Duguid J. (1960) The thrombogenic hypothesis and its implications. Postgrad Med J 36: 226–229.
8. He F. Li J. MacGregor G. (2013) Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomized trials. Br Med J 346: f1325.
9. Hoieggen A. Fossum E. Moan A. Enger E. Kjeldsen S. (1998) Whole–blood viscosity and the insulin-resistance syndrome. J Hypertens 16: 203–210.
10. Holsworth R. Jr Cho Y. Weidman J. Sloop G. St Cyr J. (2014) Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables. Perfusion 29: 102–116.
11. Holsworth R. Jr Sloop G. Weidman J. (2013) Review of major epidemiologic studies of blood viscosity in cardiovascular diseases. Integr Med Clinician's J 12: 24–35.
12. Houschyar K. Lüdtke R. Dobos G. Kalus U. Broecker-Preuss M. Rampp T. et al. (2012) Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC Med 10: 54.
13. Julius S. Gudbrandsson T. Jamerson K. Shabab S. Andersson O. (1991) The hemodynamic link between insulin resistance and hypertension. J Hypertens 9: 983–986.
14. Kawasaki T. Kambayashi J. Ariyoshi H. Sakon M. Suehisa E. Monden M. (1997) Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 88: 67–73.
15. Kragel A. Reddy S. Wittes J. Roberts W. (1990) Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 66: 562–567.
16. Letcher R. Chien S. Pickering T. Laragh J. (1983) Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5: 757–762.
17. Letcher R. Chien S. Pickering T. Sealey J. Laragh J. (1981) Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 70: 1195–1202.
18. Lominadze D. Joshua I. Schuschke D. (1998) Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 11: 784–789.
19. Lowe G. Lee A. Rumley A. Price J. Fowkes F. (1997). Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 96: 168–173.
20. Majno G. Joris I. (2004) Cells, Tissue and Disease: General Principles of Pathology, 2nd edn. Oxford, New York: Oxford University Press.
21. Nichols M. O'Rourke M. (1998) McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 4th edn. London: Arnold.
22. Pathobiological Determinants of Atherosclerosis on Youth Research Group (1993) Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY study. Arterioscler Thromb Vasc Biol 13: 1291–1298.
23. Perret R. Sloop G. (2000) Increased peak blood velocity in association with elevated blood pressure. Ultrasound Med Biol 26: 1387–1391.
24. Reference Values for Arterial Stiffness’ Collaboration (2010) Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 31: 2338–2350.
25. Ridker P. Libby P. (2011) Risk markers for atherothromobtic diseases. In: Ed. Bonow R. Mann D. Zipes D. Libby P. (eds), Braunwald's Heart Disease – A Textbook of Cardiovascular Medicine, 9th edn. Philadelphia: Elsevier Saunders.
26. Rosenson R. McCormick A. Uretz E. (1996) Distribution of blood viscosity values and biochemical correlates in healthy adults. Clin Chem 42: 1189–1195.
27. Schmid-Schonbein H. Wells R. Goldstone J. (1969) Influence of deformability of human red cells upon blood viscosity. Circ Res 25: 131–143.
28. Scheoinhagen P. Tuzcu E.M. Ellis S.G. (2002) Plaque vulnerability, plaque rupture, and acute coronary syndromes. Circulation 106: 760–762.
29. Sloop G. (1996) A unifying theory of atherogenesis. Med Hypotheses 47: 321–325.
30. Sloop G. (1999) A critical analysis of the role of cholesterol in atherogenesis. Atherosclerosis 142: 265–268.
31. Sloop G. Fallon K. Zieske A. (2002) Atherosclerotic plaque-like lesions in synthetic arteriovenous grafts: implications for atherogenesis. Atherosclerosis 160: 133–139.
32. Sloop G. Garber D. (1997) The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond) 92: 473–479.
33. Sloop G. Perret R. Brahney J. Oalmann M. (1998) A description of two morphologic patterns of aortic fatty streaks, and a hypothesis of their pathogenesis. Atherosclerosis 141: 153–160.
34. Smith E. Slater R. Chu P. (1968) The lipids in raised fatty and fibrous lesions in human aorta. J Atheroscler Res 8: 399–419.
35. Stary H. Chandler A. Dinsmore R. Fuster V. Glagov S. Insull W. Jr et al. (1995) A definition of advanced types of atherosclerotic lesions and a histologic classification of atherosclerosis. Circulation 92: 1355–1374.
36. Taubes G. (1998) The (political) science of salt. Science 281: 898–907.
37. van der Steeg W. Holme I. Boekhardt S. Boekholdt S. Larsen M. Lindahl C. et al. (2008) High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I. Significance for cardiovascular risk. The IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol 51: 634–642.
38. van Oss C. Absolom D. (1983) Zeta potentials, van der Waals forces and hemagglutination. Vox Sang 44: 183–190.
39. Velcheva I. Antonova N. Titianova E. Damianov P. Dimitrov N. Dimitrova V. (2008) Hemorheological disturbances in cerebrovascular diseases. Clin Hemorheol Microcirc 39: 391–396.
40. Wentzel J. Chatzizisis Y. Gijsen F. Giannoglou G. Feldman C. Stone P. (2012) Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions. Cardiovasc Res 6: 234–243.